ORICA LIMITED (ORI)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ORI

ORI - ORICA LIMITED

FNArena Sector : Mining Sector Contracting
Year End: September
GICS Industry Group : Materials
Debt/EBITDA: 2.3
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Orica is an Australian multinational company that is one of the world's largest providers of commercial explosives and blasting systems to the mining, quarrying, oil and gas and construction industry.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$21.40

19 Nov
2026

-0.270

OPEN

$21.67

-1.25%

HIGH

$21.67

2,007,123

LOW

$21.25

TARGET
$26.79 25.2% upside
OTHER COMPANIES IN THE SAME SECTOR
ALQ . ANG . ARI . C79 . CDA . DNL . DOW . EHL . GNG . IMD . IPG . LBL . LYL . MAD . MAH . MIN . MLG . MND . MSV . MYE . NWH . PRN . RAN . RCR . RKT . SGH . SRG . SXE . TEA . VBC . XRF .
FNARENA'S MARKET CONSENSUS FORECASTS
ORI: 1
Title FY25
Actual
FY26
Actual
FY27
Forecast
FY28
Forecast
EPS (cps) xxx 56.8 134.2 xxx
DPS (cps) xxx 64.0 69.2 xxx
EPS Growth xxx 69.4% 100.0% xxx
DPS Growth xxx 12.3% 8.1% xxx
PE Ratio xxx N/A 15.3 xxx
Dividend Yield xxx N/A 3.4% xxx
Div Pay Ratio(%) xxx 112.6% 51.6% xxx

Dividend yield today if purchased 3 years ago: 4.08%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

3.11

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

$ 

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 17/11 - (franking ex-div 35.50c)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx56.8
DPS All xxxxxxxxxxxxxxx64.0
Sales/Revenue xxxxxxxxxxxxxxx8,263.5 M
Book Value Per Share xxxxxxxxxxxxxxx811.9
Net Operating Cash Flow xxxxxxxxxxxxxxx758.3 M
Net Profit Margin xxxxxxxxxxxxxxx3.20 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx6.66 %
Return on Invested Capital xxxxxxxxxxxxxxx3.93 %
Return on Assets xxxxxxxxxxxxxxx2.59 %
Return on Equity xxxxxxxxxxxxxxx6.66 %
Return on Total Capital xxxxxxxxxxxxxxx12.47 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx19.6 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx524 M
Long Term Debt xxxxxxxxxxxxxxx2,713 M
Total Debt xxxxxxxxxxxxxxx3,237 M
Goodwill - Gross xxxxxxxxxxxxxxx2,625 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx762 M
Price To Book Value xxxxxxxxxxxxxxx2.89

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx506.3 M
Capex % of Sales xxxxxxxxxxxxxxx6.13 %
Cost of Goods Sold xxxxxxxxxxxxxxx6,738 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx630 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx270 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgans

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

13/11/2026

1

Buy

$26.95

25.93%

On further inspection, post the initial observations below, Citi sees FY27 as a "cleaner" year with fewer significant items. Growth is expected to continue against continuing turnarounds and higher investment.

The broker remains Buy rated and flags the stock is expected to outperform into the upcoming investor day, a potential catalyst. Target price is lifted to $26.95 from $25.40.

At first look, Orica's FY26 EBIT came in 2% better than consensus, due to stronger performances from Digital and Specialty Chemicals, while Blasting was broadly in line.

Citi highlights weaker cash flow, down -20% y/y, reflecting -$344m in significant items, with net debt rising to 1.46x.

Blasting EBIT was marginally ahead of consensus, although the analyst queries earnings quality given around -$20m in US supply disruption costs appear to have been excluded from underlying earnings in 2H26.

Digital EBIT beat consensus by 4%, supported by revenue growth of 16% y/y, while Specialty Chemicals EBIT of $126m was 6% ahead, benefiting from 9% higher sodium cyanide volumes.

The broker expects minimal to low-single-digit NPAT revisions for FY27, with uncertainty remaining around US supply disruptions and their earnings treatment. Buy. Target $25.40.

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

30/10/2026

1

Upgrade to Buy from Overweight

$26.00

21.50%

Jarden upgrades to a Buy rating for Orica with its target price decreased to $26.00 from $26.40 ahead of the FY26 result scheduled for November.

Forecast FY26 underlying EBIT of $1,045m sits slightly ahead of consensus expectations of $1,039m.

The analyst notes a recent update provided confidence regarding US ammonium nitrate supply for FY27, though concerns remain over the short 12-month contract duration and potential margin impacts from higher sourcing costs.

The company intends to mitigate the cost impost through targeted savings initiatives.

Jarden downgrades core EPS estimates by -2% across FY27 and FY28 to account for weaker Blasting Solutions EBIT expectations, driving the target price reduction alongside updated valuation inputs.

ORI STOCK CHART